Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]

Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

OMED Health, a UK-based company developing non-invasive breath analysis tools [...]

Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]

Selection of CRO marks key milestone in advancing CS1 as [...]

Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]

Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

Deal gives Shionogi access to BioVersys’ BV500 program targeting serious [...]

Data presented at ISTH 2025 highlight potential for improved outcomes [...]